Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Irreversible Inhibition of EGFR: Modeling the Combined Pharmacokinetic-Pharmacodynamic Relationship of Osimertinib and Its Active Metabolite AZ5104.

Yates JW, Ashton S, Cross D, Mellor MJ, Powell SJ, Ballard P.

Mol Cancer Ther. 2016 Oct;15(10):2378-2387. Epub 2016 Jul 20.

2.

Incidence, risk factors and the healthcare cost of falls postdischarge after elective total hip and total knee replacement surgery: protocol for a prospective observational cohort study.

Hill AM, Ross-Adjie G, McPhail SM, Monterosso L, Bulsara M, Etherton-Beer C, Powell SJ, Hardisty G.

BMJ Open. 2016 Jul 13;6(7):e011139. doi: 10.1136/bmjopen-2016-011139.

3.

Impact of the anesthesiologist and surgeon on cardiac surgical outcomes.

Papachristofi O, Mackay JH, Powell SJ, Nashef SAM, Sharples L.

J Cardiothorac Vasc Anesth. 2014 Feb;28(1):103-109. doi: 10.1053/j.jvca.2013.07.004. Epub 2013 Oct 30.

4.

RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor Cediranib.

Bradford JR, Farren M, Powell SJ, Runswick S, Weston SL, Brown H, Delpuech O, Wappett M, Smith NR, Carr TH, Dry JR, Gibson NJ, Barry ST.

PLoS One. 2013 Jun 19;8(6):e66003. doi: 10.1371/journal.pone.0066003. Print 2013.

5.

Six-year prospective audit of 'scoop and run' for chest-reopening after cardiac arrest in a cardiac surgical ward setting.

Lees NJ, Powell SJ, Mackay JH.

Interact Cardiovasc Thorac Surg. 2012 Nov;15(5):816-23. doi: 10.1093/icvts/ivs343. Epub 2012 Aug 9.

6.

Rapid generation of a high quality lead for transforming growth factor-beta (TGF-beta) type I receptor (ALK5).

Goldberg FW, Ward RA, Powell SJ, Debreczeni JE, Norman RA, Roberts NJ, Dishington AP, Gingell HJ, Wickson KF, Roberts AL.

J Med Chem. 2009 Dec 10;52(23):7901-5. doi: 10.1021/jm900807w.

PMID:
19736928
7.

Early outcomes of tricuspid valve replacement in young children.

Bartlett HL, Atkins DL, Burns TL, Engelkes KJ, Powell SJ, Hills CB, Moller JH.

Circulation. 2007 Jan 23;115(3):319-25. Epub 2007 Jan 2.

8.

Local clinical quality monitoring for detection of excess operative deaths.

Arrowsmith JE, Powell SJ, Nashef SA.

Anaesthesia. 2006 May;61(5):423-6.

9.

Total arterial revascularization is safe: multicenter ten-year analysis of 71,470 coronary procedures.

Baskett RJ, Cafferty FH, Powell SJ, Kinsman R, Keogh BE, Nashef SA.

Ann Thorac Surg. 2006 Apr;81(4):1243-8.

PMID:
16564251
11.
12.

Resuscitation after cardiac surgery: are we ageist?

Mackay JH, Powell SJ, Charman SC, Rozario C.

Eur J Anaesthesiol. 2004 Jan;21(1):66-71.

PMID:
14768926
13.

Six-year prospective audit of chest reopening after cardiac arrest.

Mackay JH, Powell SJ, Osgathorp J, Rozario CJ.

Eur J Cardiothorac Surg. 2002 Sep;22(3):421-5.

PMID:
12204734
14.

POSSUM and Portsmouth POSSUM for predicting mortality. Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity.

Prytherch DR, Whiteley MS, Higgins B, Weaver PC, Prout WG, Powell SJ.

Br J Surg. 1998 Sep;85(9):1217-20.

PMID:
9752863
15.

Cloning, sequencing and functional expression of a guinea pig lung bradykinin B2 receptor.

Farmer SG, Powell SJ, Wilkins DE, Graham A.

Eur J Pharmacol. 1998 Apr 10;346(2-3):291-8.

PMID:
9652372
16.

Human bradykinin B2 receptor: nucleotide sequence analysis and assignment to chromosome 14.

Powell SJ, Slynn G, Thomas C, Hopkins B, Briggs I, Graham A.

Genomics. 1993 Feb;15(2):435-8.

PMID:
7916737
17.

Inhibition of biofilm populations of Nitrosomonas europaea.

Powell SJ, Prosser JI.

Microb Ecol. 1992 Jul;24(1):43-50. doi: 10.1007/BF00171969.

PMID:
24193038
18.

Isolation and characterisation of the human lung NK-1 receptor cDNA.

Hopkins B, Powell SJ, Danks P, Briggs I, Graham A.

Biochem Biophys Res Commun. 1992 Feb 14;182(3):1514. No abstract available.

PMID:
1311575
19.

Human NK-2 receptor gene maps to chromosome region 10q11-21.

Morten JE, Hopkins B, Powell SJ, Graham A.

Hum Genet. 1991 Dec;88(2):200-3.

PMID:
1661704
20.

Isolation and characterisation of the human lung NK-1 receptor cDNA.

Hopkins B, Powell SJ, Danks P, Briggs I, Graham A.

Biochem Biophys Res Commun. 1991 Oct 31;180(2):1110-7. Erratum in: Biochem Biophys Res Commun. 1992 Feb 14;182(3):1514.

PMID:
1659396
21.
22.

Isolation and characterisation of the human lung NK-2 receptor gene using rapid amplification of cDNA ends.

Graham A, Hopkins B, Powell SJ, Danks P, Briggs I.

Biochem Biophys Res Commun. 1991 May 31;177(1):8-16.

PMID:
1710456
23.

Enzyme immunoassay for the determination of atrazine residues in soil.

Goh KS, Hernandez J, Powell SJ, Garretson C, Troiano J, Ray M, Greene CD.

Bull Environ Contam Toxicol. 1991 Jan;46(1):30-6. No abstract available.

PMID:
2001490
24.

A yeast artificial chromosome contig encompassing the cystic fibrosis locus.

Anand R, Ogilvie DJ, Butler R, Riley JH, Finniear RS, Powell SJ, Smith JC, Markham AF.

Genomics. 1991 Jan;9(1):124-30.

PMID:
1706309
25.

Atrazine soil residue analysis by enzyme immunoassay: solvent effect and extraction efficiency.

Goh KS, Hernandez J, Powell SJ, Greene CD.

Bull Environ Contam Toxicol. 1990 Aug;45(2):208-14. No abstract available.

PMID:
2205313
27.
28.

Nucleotide sequence of cDNA for human aldose reductase.

Graham A, Hedge PJ, Powell SJ, Riley J, Brown L, Gammack A, Carey F, Markham AF.

Nucleic Acids Res. 1989 Oct 25;17(20):8368. No abstract available.

29.

ATP synthase from bovine mitochondria: complementary DNA sequence of the import precursor of a heart isoform of the alpha subunit.

Walker JE, Powell SJ, Viñas O, Runswick MJ.

Biochemistry. 1989 May 30;28(11):4702-8.

PMID:
2527557
31.

Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS).

Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, Markham AF.

Nucleic Acids Res. 1989 Apr 11;17(7):2503-16.

32.

Two bovine genes for mitochondrial ADP/ATP translocase expressed differences in various tissues.

Powell SJ, Medd SM, Runswick MJ, Walker JE.

Biochemistry. 1989 Jan 24;28(2):866-73.

PMID:
2540808
33.
35.

Structure and genes of ATP synthase.

Walker JE, Cozens AL, Dyer MR, Fearnley IM, Powell SJ, Runswick MJ.

Biochem Soc Trans. 1987 Feb;15(1):104-6. No abstract available.

PMID:
3030835
36.

Inhibition of ammonium oxidation by nitrapyrin in soil and liquid culture.

Powell SJ, Prosser JI.

Appl Environ Microbiol. 1986 Oct;52(4):782-7.

37.

Primary structure and subunit stoichiometry of F1-ATPase from bovine mitochondria.

Walker JE, Fearnley IM, Gay NJ, Gibson BW, Northrop FD, Powell SJ, Runswick MJ, Saraste M, Tybulewicz VL.

J Mol Biol. 1985 Aug 20;184(4):677-701.

PMID:
2864455
38.

The profile in facial aesthetics.

Powell SJ, Rayson RK.

Br J Orthod. 1976 Oct;3(4):207-15. No abstract available.

PMID:
1068711
39.

The surgical treatment of bi-maxillary dento-alveolar proclination.

Henry TC, Powell SJ.

Br Dent J. 1976 Jul 20;141(2):39-47. No abstract available.

PMID:
1065344
40.

Clinical trials of benzoyl metronidazole suspension in amoebic dysentery and amoebic liver abscess.

Powell SJ, Rubidge CJ, Elsdondew R.

S Afr Med J. 1974 Mar 31;47(12):507-8. No abstract available.

PMID:
4826757
41.

Metronidazole in treatment of children with amoebic liver abscess.

Scragg JN, Powell SJ.

Arch Dis Child. 1973 Nov;48(11):911-2. No abstract available.

42.

Haemobilia in amoebic liver abscess.

Powell SJ, Sutton JB, Lautré G.

S Afr Med J. 1973 Sep 1;47(34):1555-7. No abstract available.

PMID:
4734026
43.

Metronidazole combined with diloxanide furoate in amoebic liver abscess.

Powell SJ, Stewart-Wynne EJ, Elsdon-Dew R.

Ann Trop Med Parasitol. 1973 Sep;67(3):367-8. No abstract available.

PMID:
4357547
44.

Difetarsone in the treatment of Trichuris trichiura infections.

Rubidge CJ, O'Dowd PB, Powell SJ.

S Afr Med J. 1973 Jun 16;47(23):991-2. No abstract available.

PMID:
4714286
45.

The treatment of intestinal and hepatic amoebiasis.

Powell SJ.

S Afr Med J. 1973 Mar 10;47(10):452-3. No abstract available.

PMID:
4690078
46.

Some new nitroimidazole derivatives. Clinical trials in amebic liver abscess.

Powell SJ, Elsdon-Dew R.

Am J Trop Med Hyg. 1972 Sep;21(5):518-20. No abstract available.

PMID:
4561689
47.

Latest developments in the treatment of amebiasis.

Powell SJ.

Adv Pharmacol Chemother. 1972;10:91-103. No abstract available.

PMID:
4364760
48.

Evaluation of metronidazole and MK-910 in invasive amebiasis.

Powell SJ, Elsdon-Dew R.

Am J Trop Med Hyg. 1971 Nov;20(6):839-41. No abstract available.

PMID:
4331956
49.

Invasive amoebiasis: circulating antibody levels by latex agglutination test.

Morris MN, Powell SJ, Elsdon-Dew R.

S Afr Med J. 1971 Oct 30;45(42):1206-8. No abstract available.

PMID:
4331607
50.

Antibody response to invasive amebiasis in Durban, South Africa.

Krupp IM, Powell SJ.

Am J Trop Med Hyg. 1971 May;20(3):414-20. No abstract available.

PMID:
4996706

Supplemental Content

Loading ...
Support Center